• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于无框架单分割直线加速器的立体定向放射外科治疗脑转移瘤的剂量-体积反应关系

Dose-Volume Response Relationship for Brain Metastases Treated with Frameless Single-Fraction Linear Accelerator-Based Stereotactic Radiosurgery.

作者信息

Amsbaugh Mark, Pan Jianmin, Yusuf Mehran B, Dragun Anthony, Dunlap Neal, Guan Timothy, Boling Warren, Rai Shesh, Woo Shiao

机构信息

Radiation Oncology, University of Louisville.

JG Brown Cancer Center, University of Louisville.

出版信息

Cureus. 2016 Apr 27;8(4):e587. doi: 10.7759/cureus.587.

DOI:10.7759/cureus.587
PMID:27284495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4889452/
Abstract

BACKGROUND

Our aim was to identify a dose-volume response relationship for brain metastases treated with frameless stereotactic radiosurgery (SRS).

METHODS

We reviewed patients who underwent frameless single-fraction linear accelerator SRS for brain metastases between 2007 and 2013 from an institutional database. Proportional hazards modeling was used to identify predictors of outcome. A ratio of maximum lesion dose per mm-diameter (Gy/mm) was constructed to establish a dose-volume relationship.

RESULTS

There were 316 metastases evaluated in 121 patients (2 - 33 mm in the largest diameter). The median peripheral dose was 18.0 Gy (range: 10.0 - 24.0 Gy). Local control was 84.8% for all lesions and was affected by location, peripheral dose, maximum dose, and lesion size (p values < 0.050). A dose-volume response relationship was constructed using the maximum dose and lesion size. A unit increase in Gy/mm was associated with decreased local failure (p = 0.005). Local control of 80%, 85%, and 90% corresponded to maximum doses per millimeter of 1.67 Gy/mm, 2.86 Gy/mm, and 4.4 Gy/mm, respectively. Toxicity was uncommon and only 1.0% of lesions developed radionecrosis requiring surgery.

CONCLUSIONS

For brain metastases less than 3 cm, a dose-volume response relationship exists between maximum radiosurgical dose and lesion size, which is predictive of local control.

摘要

背景

我们的目的是确定无框架立体定向放射外科(SRS)治疗脑转移瘤的剂量-体积反应关系。

方法

我们从机构数据库中回顾了2007年至2013年间接受无框架单分割直线加速器SRS治疗脑转移瘤的患者。采用比例风险模型确定预后的预测因素。构建每毫米直径最大病变剂量(Gy/mm)的比值以建立剂量-体积关系。

结果

121例患者共评估了316个转移瘤(最大直径2 - 33mm)。中位周边剂量为18.0Gy(范围:10.0 - 24.0Gy)。所有病变的局部控制率为84.8%,受位置、周边剂量、最大剂量和病变大小影响(p值<0.050)。使用最大剂量和病变大小构建剂量-体积反应关系。Gy/mm每增加一个单位,局部失败率降低(p = 0.005)。局部控制率达到80%、85%和90%时,每毫米的最大剂量分别对应1.67Gy/mm、2.86Gy/mm和4.4Gy/mm。毒性不常见,仅1.0%的病变发生放射性坏死需要手术治疗。

结论

对于直径小于3cm的脑转移瘤,最大放射外科剂量与病变大小之间存在剂量-体积反应关系,可预测局部控制情况。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/8bfd4c0d0bd1/cureus-0008-000000000587-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/1d46dcc1eb45/cureus-0008-000000000587-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/af8a3cdaf1fd/cureus-0008-000000000587-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/8bfd4c0d0bd1/cureus-0008-000000000587-i03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/1d46dcc1eb45/cureus-0008-000000000587-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/af8a3cdaf1fd/cureus-0008-000000000587-i02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fdd/4889452/8bfd4c0d0bd1/cureus-0008-000000000587-i03.jpg

相似文献

1
Dose-Volume Response Relationship for Brain Metastases Treated with Frameless Single-Fraction Linear Accelerator-Based Stereotactic Radiosurgery.基于无框架单分割直线加速器的立体定向放射外科治疗脑转移瘤的剂量-体积反应关系
Cureus. 2016 Apr 27;8(4):e587. doi: 10.7759/cureus.587.
2
A Dose-Volume Response Model for Brain Metastases Treated With Frameless Single-Fraction Robotic Radiosurgery: Seeking to Better Predict Response to Treatment.用于无框架单分割机器人放射外科治疗脑转移瘤的剂量-体积反应模型:旨在更好地预测治疗反应。
Technol Cancer Res Treat. 2017 Jun;16(3):344-351. doi: 10.1177/1533034616685025. Epub 2016 Dec 27.
3
Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.2 期立体定向放射外科治疗 ≥ 2 cm 的脑转移瘤的影响。
J Neurosurg. 2018 Aug;129(2):366-382. doi: 10.3171/2017.3.JNS162532. Epub 2017 Sep 22.
4
Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.脑转移瘤立体定向放射治疗后的不良放射效应:发生率、时间进程及危险因素
J Neurosurg. 2015 Aug;123(2):373-86. doi: 10.3171/2014.10.JNS141610. Epub 2015 May 15.
5
Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.伽玛刀处方剂量对 2cm 或以下小(脑)转移瘤局部控制的影响。
J Neurosurg. 2017 Mar;126(3):735-743. doi: 10.3171/2016.3.JNS153014. Epub 2016 May 27.
6
Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.对既往行放射外科治疗后局部复发的脑转移瘤行重复立体定向放射外科治疗作为挽救性治疗。
J Neurosurg. 2017 Jul;127(1):148-156. doi: 10.3171/2016.5.JNS153051. Epub 2016 Aug 5.
7
Single-Fraction Radiosurgery Using Conservative Doses for Brain Metastases: Durable Responses in Select Primaries With Limited Toxicity.采用保守剂量的单次分割放射外科治疗脑转移瘤:在毒性有限的情况下,部分原发性肿瘤获得持久缓解。
Neurosurgery. 2018 Sep 1;83(3):437-444. doi: 10.1093/neuros/nyx427.
8
Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation.脑转移瘤的无框架立体定向放射外科治疗:疗效及预后评分评估综述
Hong Kong Med J. 2017 Dec;23(6):599-608. doi: 10.12809/hkmj166138. Epub 2017 Nov 10.
9
Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.单次分割放射外科与分次立体定向放疗治疗脑转移瘤患者的比较研究。
Clin Exp Metastasis. 2020 Jun;37(3):425-434. doi: 10.1007/s10585-020-10031-5. Epub 2020 Mar 17.
10
Frameless Stereotactic Radiosurgery With Linear Accelerator (LINAC)-Based Technology for Brain Metastases: Outcomes Analysis in 141 Patients.基于直线加速器(LINAC)技术的无框架立体定向放射外科治疗脑转移瘤:141例患者的疗效分析
Cureus. 2021 Jun 6;13(6):e15475. doi: 10.7759/cureus.15475. eCollection 2021 Jun.

引用本文的文献

1
Factors associated with the local control of brain metastases: a systematic search and machine learning application.与脑转移瘤局部控制相关的因素:系统搜索和机器学习应用。
BMC Med Inform Decis Mak. 2024 Jun 21;24(1):177. doi: 10.1186/s12911-024-02579-z.
2
Dose-Incorporated Deep Ensemble Learning for Improving Brain Metastasis Stereotactic Radiosurgery Outcome Prediction.基于剂量整合的深度集成学习改善脑转移瘤立体定向放射外科治疗预后预测。
Int J Radiat Oncol Biol Phys. 2024 Oct 1;120(2):603-613. doi: 10.1016/j.ijrobp.2024.04.006. Epub 2024 Apr 12.
3
Dose-effect relationship of linear accelerator based stereotactic radiotherapy for brain metastases.

本文引用的文献

1
Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.对初始 SRS 后新出现的脑转移瘤重复行立体定向放射外科(SRS)治疗,推迟全脑放疗。
Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):993-999. doi: 10.1016/j.ijrobp.2015.04.036. Epub 2015 Apr 28.
2
Local control after radiosurgery for brain metastases: predictive factors and implications for clinical decision.脑转移瘤立体定向放射治疗后的局部控制:预测因素及对临床决策的影响
Radiat Oncol. 2015 Mar 8;10:63. doi: 10.1186/s13014-015-0367-y.
3
Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis.
基于直线加速器的立体定向放射治疗脑转移瘤的剂量-效应关系。
Radiat Oncol. 2023 Oct 30;18(1):177. doi: 10.1186/s13014-023-02360-y.
4
Factors correlating with survival following adjuvant or definitive radiosurgery for large brain metastases.大体积脑转移瘤辅助或根治性放射手术后与生存相关的因素。
Neuro Oncol. 2022 Nov 2;24(11):1925-1934. doi: 10.1093/neuonc/noac106.
5
Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases.脑转移瘤患者伽玛刀放射手术后症状性治疗相关改变的组织病理学和手术结果。
Sci Rep. 2022 Feb 22;12(1):3013. doi: 10.1038/s41598-022-06881-6.
6
Stereotactic radiosurgery for melanoma brain metastases: dose-size response relationship in the era of immunotherapy.立体定向放射外科治疗黑色素瘤脑转移瘤:免疫治疗时代的剂量-体积反应关系。
J Neurooncol. 2022 Jan;156(1):163-172. doi: 10.1007/s11060-021-03899-0. Epub 2021 Nov 22.
7
Clinical and volumetric predictors of local control after robotic stereotactic radiosurgery for cerebral metastases: active systemic disease may affect local control in the brain.机器人立体定向放射外科治疗脑转移瘤后局部控制的临床和体积预测因素:活动性全身疾病可能影响脑内局部控制。
Radiol Oncol. 2020 Nov 10;55(1):82-87. doi: 10.2478/raon-2020-0065.
8
Evaluating the natural growth rate of metastatic cancer to the brain.评估脑转移癌的自然生长率。
Surg Neurol Int. 2020 Aug 21;11:254. doi: 10.25259/SNI_291_2020. eCollection 2020.
9
Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.单剂量和多剂量立体定向放射外科治疗脑的剂量/体积耐受量。
Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):68-86. doi: 10.1016/j.ijrobp.2020.08.013. Epub 2020 Sep 11.
10
Two-Session Radiosurgery for Large Primary Tumors Affecting the Brain.针对影响脑部的大型原发性肿瘤的两阶段放射外科治疗。
Cureus. 2020 Apr 27;12(4):e7850. doi: 10.7759/cureus.7850.
1 至 4 个脑转移瘤立体定向放射外科与或不伴全脑放疗的 3 期临床试验:个体患者数据荟萃分析。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):710-7. doi: 10.1016/j.ijrobp.2014.10.024.
4
Impact of millimeter-level margins on peripheral normal brain sparing for gamma knife radiosurgery.毫米级切缘对伽玛刀放射外科周边正常脑组织保护的影响。
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):206-13. doi: 10.1016/j.ijrobp.2014.01.011.
5
Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.单独接受放射外科治疗的患者中,递归分区分析和诊断特异性分级预后评估的验证。
J Neurosurg. 2012 Dec;117 Suppl(0):38-44. doi: 10.3171/2012.3.GKS1289.
6
Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.立体定向放射外科治疗脑转移瘤:疗效和放射性脑坏死风险分析。
Radiat Oncol. 2011 May 15;6:48. doi: 10.1186/1748-717X-6-48.
7
Dose-effect relation in stereotactic radiotherapy for brain metastases. A systematic review.立体定向放疗治疗脑转移瘤的剂量效应关系。系统评价。
Radiother Oncol. 2011 Mar;98(3):292-7. doi: 10.1016/j.radonc.2011.01.011.
8
Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.术后全脑放疗与观察对 1 至 3 个脑转移瘤放疗或手术切除后的影响:EORTC 22952-26001 研究结果。
J Clin Oncol. 2011 Jan 10;29(2):134-41. doi: 10.1200/JCO.2010.30.1655. Epub 2010 Nov 1.
9
Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.初诊脑转移瘤患者的诊断特异性预后因素、指标和治疗结局:多机构分析 4259 例患者。
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):655-61. doi: 10.1016/j.ijrobp.2009.08.025. Epub 2009 Nov 26.
10
Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy.挽救性立体定向放射外科手术可有效治疗全脑放射治疗后的复发。
Cancer. 2008 Oct 15;113(8):2198-204. doi: 10.1002/cncr.23821.